GOG Foundation

 

GOG Foundation
Avatar

Atezolizumab + nab-Paclitaxel Confers PFS/OS in PD-L1+ mTNBC as a New Standard of Care in 1st-Line Therapy

By GOG Foundation FEATURING Leisha Emens
By GOG Foundation FEATURING Leisha Emens
177 views
January 22, 2020
0 Comments
Login to view comments. Click here to Login

Featured Video

23:46
AstraZeneca Oncology

First-line Maintenance Treatment Option in Patients With HRD-Positiv…

Feat. S. Lewin

Featured Video

17:33
AstraZeneca Oncology

First-line Maintenance Therapy for BRCAm Advanced Ovarian Cancer Fol…

Feat. S. Lewin
Winter 2020 Symposium “It’s a PARP World After All”
10:32
GOG Foundation

PARPi Benefit in Ovarian Cancer: Does PARPi Maintenance Prolong PFS …

Feat. J. Liu
09:08
GOG Foundation

Maintenance Therapy Clinical Trials in Newly Diagnosed Ovarian Cance…

Feat. J. Liu
05:55
GOG Foundation

Frontline Maintenance Therapy With PARPi is the Standard of Care in …

Feat. K. Moore
09:34
GOG Foundation

Clinically-Guided Interventions and New Clinical Trials Are Preferre…

Feat. M. Bookman
03:01
GOG Foundation

Frontline Maintenance Therapy With PARPi is the Standard of Care in …

Feat. K. Moore
06:03
GOG Foundation

Expanding PARPi Horizons in Gynecological Cancers: Will Women With E…

Feat. B. Rimel
08:20
GOG Foundation

Expanding PARPi Horizons in Gynecological Cancers: Cervical Cancer C…

Feat. R. Salani
16:52
GOG Foundation

Future of Clinical Trial Design in the New PARPi World in Gynecologi…

Feat. R. Coleman
20:06
GOG Foundation

PARPi Monotherapy w/ Olaparib or Talazoparib Has Established Role as…

Feat. C. Geyer
05:52
GOG Foundation

PARPi Are an Excellent Oral Option w/ Quick Time Response and Improv…

Feat. J. Litton
10:11
GOG Foundation

Atezolizumab + nab-Paclitaxel Confers PFS/OS in PD-L1+ mTNBC as a Ne…

Feat. L. Emens
24:23
GOG Foundation

PARPi as Monotherapy Have High-Level Anti-Tumor Activity in mCRPC w/…

Feat. O. Sartor
31:56
GOG Foundation

New Frontiers of PARPi Therapy in Pancreatic and Biliary Cancers: Tu…

Feat. J. Abbruzzese